Bellerophon Therapeutics
IPO- Headquarters
- New Jersey
- Employees
- 11–50
- Business Model
- B2B
- Website
- bellerophon.com
About
Portfolio company
Summary
Bellerophon Therapeutics is a Biotech company based in United States. Investors include Leerink Partners and Cowen and Company.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2015
Investors
Similar Companies
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private Equity·$5.0B·Jun 2017
Simtra BioPharma Solutions
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
PP
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA
Global fertility clinics platform
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Isomorphic Labs
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
inVentiv HealthAcquired
Biopharmaceutical services company
Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017